Pfizer Oncology Head Charles Baum: An Interview With “The Pink Sheet” DAILY (Part 2 Of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Baum talks about potential label expansions for Sutent and the early stage pipeline. Plus, Oncology Commercial Head Ayers weighs in with Pfizer’s take on licensing and acquisitions in the therapeutic area.